If I'd invested $1,000 in CSL shares 24 years ago, here's how much I'd have now!

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

| More on:
Woman looks amazed and shocked as she looks at her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Ltd (ASX: CSL) shares first listed on the ASX way back on 8 June 1994.

The S&P/ASX 200 Index biotechnology company floated for $2.30 per share. But once we take share buybacks into account, the adjusted entry price works out to around 76 cents per share.

We won't go back quite that far.

But here's how much I'd have now if I'd invested $1,000 in CSL shares 24 years ago.

Invest in CSL shares like it's 1999

Investing with perfect hindsight is a wonderful thing.

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

CSL shares certainly count among the winners.

Back on 16 April 1999, CSL closed the day trading for $4.23 per share.

That means I could have bought 236 shares with my $1,000 and had enough left over for a cup of 1999-priced coffee.

At the time of writing, CSL is trading for $304.31 per share.

If I opted to sell those 236 shares today they'd get me a whopping $71,817 and change.

In other words, the stock would have seen me gain 7,081% on my initial investment over 24 years, from share price appreciation alone.

Don't forget the dividends!

But let's not forget that CSL shares also have a lengthy track record of delivering dividends.

According to my calculations, the biotech company has paid out approximately $28 per share in dividends since April 1999. That's more than six times what I would have paid for those shares in 1999.

Assuming I didn't reinvest those dividends but simply tucked the cash under my mattress for a rainy day, I'd have earned some $6,608 in passive income from my 236 shares.

Adding that in, my total gains on that $1,000 investment in 1999 have leapt to an eye-popping 7,742%.

Granted, inflation over that period will have cut those gains roughly in half in real terms.

But still, try getting that kind of yield from your bank!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »